Filing Details
- Accession Number:
- 0000899243-22-008123
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-28 17:27:32
- Reporting Period:
- 2022-02-24
- Accepted Time:
- 2022-02-28 17:27:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789815 | Ourania Tatsis | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Reg. & Quality Off. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-02-24 | 2,590 | $227.86 | 50,514 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-02-25 | 28 | $228.88 | 50,486 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 77 | $230.26 | 50,409 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 115 | $230.97 | 50,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 87 | $231.81 | 50,207 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 18 | $232.80 | 50,189 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $228.88 (range $228.39 to $229.36).
- Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $230.26 (range $229.50 to $230.48).
- Open market sales reported on this line occurred at a weighted average price of $230.97 (range $230.50 to $231.47).
- Open market sales reported on this line occurred at a weighted average price of $231.81 (range $231.52 to $232.31).
- Open market sales reported on this line occurred at a weighted average price of $232.80 (range $232.59 to $232.92).
Billionaire Hedge Funds
